Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin?
Huysmans
Dyde A
DA
Department of Nuclear Medicine, Catharina Hospital, Eindhoven, the Netherlands.
Nieuwlaat
Willy-Anne
WA
Hermus
Ad R
AR
D003131:Combined Modality Therapy; D006044:Goiter, Nodular / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013963:Thyroid Hormones; D013972:Thyrotropin